Biostatistics, Epidemiology & Environmental Health Sciences: Faculty Publications
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations
Document Type
Article
Publication Date
5-8-2020
Publication Title
Abstract
Randomization is an essential feature of the clinical trial design (Armitage, 1982). Randomization mitigates potential for experimental bias, promotes comparability of treatment groups, and validates the use of statistical methods for inferential analysis of trial results.
Recommended Citation
Liu, Qing, Karl E. Peace.
2020.
"Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations."
LinkedIn.
source: Linkedin.com
https://digitalcommons.georgiasouthern.edu/bee-facpubs/150
Copyright
This work is archived and distributed under the repository's Standard Copyright and Reuse License (opens in new tab). End users may copy, store, and distribute this work without restriction. For all other uses, permission must be obtained from the copyright owners or their authorized agents.
